Sign in

Private company

Quotient Ltd

In vitro and in vivo diagnostic substances company1

In its 2022 annual report the company says: “We are a commercial-stage diagnostics company committed to reducing healthcare costs and improving patient care through the provision of innovative ways to test within established markets. Our initial focus is on blood grouping and donor disease screening, which is commonly referred to as transfusion diagnostics.”73

Last updated Oct 21, 2026.

Overview

$38.5MRevenue, fiscal 20222
-$125.1MNet income, fiscal 20222
  • IndustryIn Vitro & In Vivo Diagnostic Substances1
  • HeadquartersY91
  • Incorporated inJersey3
  • Business address28 Esplanade, Saint Helier, Y9 Je2 3Qa3
  • Filer categoryNon-accelerated filer, Smaller reporting company3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

38.8%Gross margin2
-269.6%Operating margin2
-324.9%Net margin2
-11.2%Revenue growth, 20222
-$121.9MFree cash flow2

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue28¢$23.6M
  • Research and development71¢$58.7M
  • Income tax1¢$961.0K

Out of $38.5M in revenue.2 The company lost money this year.

Financial statements

Revenue456782$38.5M in 2022+109% since 2015
0$20.0M$40.0M$60.0M2015: $18.4M$18.4M20152016: $18.5M$18.5M2016+1%2017: $22.2M$22.2M2017+20%2018: $24.7M$24.7M2018+11%2019: $29.1M$29.1M2019+18%2020: $32.7M$32.7M2020+12%2021: $43.4M$43.4M2021+33%2022: $38.5M$38.5M2022−11%
Gross profit456782$14.9M in 2022+73% since 2015
0$10.0M$20.0M$30.0M2015: $8.6M$8.6M20152016: $8.9M$8.9M2016+3%2017: $11.4M$11.4M2017+28%2018: $14.3M$14.3M2018+25%2019: $11.9M$11.9M2019−17%2020: $14.9M$14.9M2020+25%2021: $23.3M$23.3M2021+57%2022: $14.9M$14.9M2022−36%
Operating income456782-$103.8M in 2022+249% since 2015
-$150.0M-$100.0M-$50.0M02015: -$29.7M-$29.7M20152016: -$49.1M-$49.1M2016+65%2017: -$74.1M-$74.1M2017+51%2018: -$70.0M-$70.0M2018−5%2019: -$79.2M-$79.2M2019+13%2020: -$80.4M-$80.4M2020+2%2021: -$82.7M-$82.7M2021+3%2022: -$103.8M-$103.8M2022+26%
Net income456782-$125.1M in 2022+112% since 2015
-$150.0M-$100.0M-$50.0M02015: -$59.1M-$59.1M20152016: -$33.9M-$33.9M2016−43%2017: -$85.1M-$85.1M2017+151%2018: -$82.3M-$82.3M2018−3%2019: -$106.4M-$106.4M2019+29%2020: -$105.1M-$105.1M2020−1%2021: -$111.0M-$111.0M2021+6%2022: -$125.1M-$125.1M2022+13%
Fiscal year20152016201720182019202020212022
Revenue$18.4M4$18.5M5$22.2M6$24.7M7$29.1M8$32.7M8$43.4M2$38.5M2
Cost of revenue$9.8M4$9.7M5$10.8M6$10.5M7$17.2M8$17.8M8$20.1M2$23.6M2
Gross profit$8.6M4$8.9M5$11.4M6$14.3M7$11.9M8$14.9M8$23.3M2$14.9M2
Research and development$19.2M4$28.8M5$57.1M6$51.2M7$50.9M8$53.4M8$53.7M2$58.7M2
Operating expenses$118.8M2
Operating income-$29.7M4-$49.1M5-$74.1M6-$70.0M7-$79.2M8-$80.4M8-$82.7M2-$103.8M2
Income before tax-$124.2M2
Income tax-$649.0K7$30.0K8$58.0K8$1.3M2$961.0K2
Net income-$59.1M4-$33.9M5-$85.1M6-$82.3M7-$106.4M8-$105.1M8-$111.0M2-$125.1M2

Compare Quotient Ltd with another company

Corporate structure

Quotient Ltd sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Quotient Ltd

  • Quotient Ltd Y9

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Quotient Ltd reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$97.9M2 Mar 31, 2022$96.3M2 Mar 31, 2021+1.7%
Accumulated depreciation$64.7M2 Mar 31, 2022$57.2M2 Mar 31, 2021+13.0%
Property and equipment, net$33.2M2 Mar 31, 2022$39.1M2 Mar 31, 2021−14.9%
Finance-lease assets$908.0K2 Mar 31, 2022$1.4M2 Mar 31, 2021−34.4%
Operating-lease assets (leased space)$29.4M2 Mar 31, 2022$22.0M2 Mar 31, 2021+33.6%

Real estate and locations

ItemLatestA year beforeChange
Area of land87,200 sq ft2 Mar 31, 202287,200 sq ft8 Mar 31, 20210%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$65.1M2 Mar 31, 2022$45.7M2 Mar 31, 2021+42.4%
Marketable securities, current$2.6M2 Mar 31, 2022$66.0M2 Mar 31, 2021−96.0%
Long-term investments$15.5M2 Mar 31, 2022$02 Mar 31, 2021

Intangibles and goodwill

ItemLatestA year beforeChange
Finite-lived intangibles, gross$1.4M2 Mar 31, 2022$4.4M2 Mar 31, 2021−67.3%
Accumulated amortization$914.0K2 Mar 31, 2022$3.8M2 Mar 31, 2021−75.8%
Finite-lived intangibles, net$520.0K2 Mar 31, 2022$619.0K2 Mar 31, 2021−16.0%

Inventory

ItemLatestA year beforeChange
Inventory, total$22.0M2 Mar 31, 2022$22.0M2 Mar 31, 2021+0.1%
Raw materials$10.2M2 Mar 31, 2022$9.2M2 Mar 31, 2021+11.3%
Work in process$7.2M2 Mar 31, 2022$9.1M2 Mar 31, 2021−21.4%
Finished goods$4.7M2 Mar 31, 2022$3.7M2 Mar 31, 2021+25.2%

Leadership

Who has led Quotient Ltd, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Franz Walt2018–2021
  2. Manuel O. Mendez2021–2022

President

  1. Jeremy Stackawitz2014–2019

Chief financial officer

  1. Stephen Unger2014–2016
  2. Christopher J. Lindop2017–2019
  3. Peter Buhler2020–2021
  4. Ali Kiboro2021–2022
201520202025
Board members and other officers (23)

Timeline

  1. Jun 14, 20238-K Completed an acquisition or sale; Change to shareholders' rights; Executive or director change43
  2. Apr 27, 20238-K Change to shareholders' rights; Shareholder vote44
  3. Feb 22, 20238-K Entered a material agreement; Bankruptcy or receivership; Executive or director change45
  4. Jan 10, 20238-K Entered a material agreement; Bankruptcy or receivership; Debt or obligation accelerated46
  5. Jan 9, 20238-K Entered a material agreement47
  6. Dec 19, 20228-K Entered a material agreement; Listing notice or transfer48
  7. Dec 12, 20228-K Listing notice or transfer49
  8. Dec 8, 20228-K Entered a material agreement; Exit or restructuring costs50
  9. Nov 22, 20228-K Entered a material agreement; Other events51
  10. Nov 4, 20228-K Change to shareholders' rights; Executive or director change; Bylaws or fiscal year changed52
  11. Sep 30, 20228-K Executive or director change53
  12. Aug 11, 20228-K Listing notice or transfer54
  13. Apr 5, 2021New chief executive Manuel O. Mendez becomes CEO15
  14. Jun 1, 2018New chief executive Franz Walt becomes CEO16

Calendar

When it reported results

  1. Aug 9, 2022Reported quarterly or annual results55
  2. Jun 24, 2022Reported quarterly or annual results56
  3. Feb 8, 2022Reported quarterly or annual results57
  4. Nov 16, 2021Reported quarterly or annual results58

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

201 filings to the SEC since October 2021: 2 annual reports, 6 quarterly reports, 29 major events, 77 insider forms, 29 large holders, 58 other. The latest 20:

  1. Jun 30, 202315-12G EDGAR
  2. Jun 29, 2023EFFECT EDGAR
  3. Jun 29, 2023EFFECT EDGAR
  4. Jun 29, 2023EFFECT EDGAR
  5. Jun 29, 2023EFFECT EDGAR
  6. Jun 29, 2023EFFECT EDGAR
  7. Jun 29, 2023EFFECT EDGAR
  8. Jun 29, 2023EFFECT EDGAR
  9. Jun 29, 2023EFFECT EDGAR
  10. Jun 26, 2023POS AM EDGAR
  11. Jun 26, 2023POS AM EDGAR
  12. Jun 26, 2023POS AM EDGAR
  13. Jun 26, 2023POS AM EDGAR
  14. Jun 26, 2023POS AM EDGAR
  15. Jun 26, 2023POS AM EDGAR
  16. Jun 26, 2023POS AM EDGAR
  17. Jun 26, 2023POS AM EDGAR
  18. Jun 26, 2023S-8 POS EDGAR
  19. Jun 26, 2023S-8 POS EDGAR
  20. Jun 26, 2023S-8 POS EDGAR

The 201 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

25 open-market trades by officers, directors and large owners since October 2021: 12 buys and 13 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Nov 25, 2022Buckle IsabelleDirectorSale1,014$0.88$892Form 4
Nov 18, 2022von Prondzynski HeinoDirectorSale25,000$1.18$29.5KForm 4
Oct 31, 2022PERCEPTIVE ADVISORS LLC10% ownerSale8,255,607$0.08$660.4KForm 4
Sep 15, 2022von Prondzynski HeinoDirectorBuy700,000$0.20$140.0KForm 4
Sep 13, 2022von Prondzynski HeinoDirectorBuy100,000$0.19$19.0KForm 4
Sep 6, 2022von Prondzynski HeinoDirectorBuy100,000$0.17$17.0KForm 4
Sep 1, 2022von Prondzynski HeinoDirectorBuy100,000$0.18$18.0KForm 4
Jul 31, 2022Buckle IsabelleDirectorSale2,479Form 4
Jul 31, 2022McDonough BrianDirectorSale2,384Form 4
Jun 30, 2022Hallsworth FrederickDirectorBuy84,808$0.24$20.4KForm 4
Jun 24, 2022SHROFF ZUBEENDirectorBuy4,666,666$0.30$1.4MForm 4
Jun 24, 2022WILKERSON L JOHNDirectorBuy4,666,666$0.30$1.4MForm 4
Jun 24, 2022Mendez Manuel O.Chief Executive OfficerBuy66,666$0.30$20.0KForm 4
Jun 24, 2022Kiboro AliChief Financial OfficerBuy66,666$0.30$20.0KForm 4
May 2, 2022Buckle IsabelleDirectorSale2,209$0.52$1.1KForm 4
May 2, 2022McDonough BrianDirectorSale2,124$0.52$1.1KForm 4
May 2, 2022Buckle IsabelleDirectorSale2,143Form 4
May 2, 2022McDonough BrianDirectorSale2,060Form 4
Feb 24, 2022von Prondzynski HeinoDirectorBuy28,894$1.31$37.9KForm 4
Feb 23, 2022von Prondzynski HeinoDirectorBuy31,106$1.28$39.8KForm 4

All 25 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Quotient Ltd is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARQuotient Ltd1
  • CIK0001596946
  • Employer ID (EIN)26-47197971
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inJersey1
  • Fiscal year endsMarch 311
  • Industry code (SIC)2835 In Vitro & In Vivo Diagnostic Substances1
  • Business address28 Esplanade, Saint Helier, Y9 JE2 3QA1
  • Phone412748322861
  • Shares outstanding4,035,013 as of Feb 2, 202311
  • Public float$180.6M as of Sep 30, 20212
  • On EDGAR sinceJan 22, 20141
  • Filings863 in all: 4 (383), 8-K (131), SC 13G/A (43), 3 (29), 10-Q (27), EFFECT (22), SC 13G (22), S-8 (18)1
    All 48 form types

    S-8 POS (18), CORRESP (17), 424B5 (16), 424B3 (12), UPLOAD (12), POS AM (10), S-3 (10), SC 13D (10), 10-K (9), DEF 14A (9), SC 13D/A (8), CT ORDER (7), S-1/A (7), 8-A12B/A (3), D (3), DEFA14A (3), 10-K/A (2), 25-NSE (2), 3/A (2), 4/A (2), CERTNAS (2), DEFR14A (2), FWP (2), S-1 (2), SD (2), SEC STAFF LETTER (2), 10-Q/A (1), 144 (1), 15-12G (1), 25 (1), 424B4 (1), 8-A12B (1), 8-K/A (1), DEFM14A (1), DRS (1), NT 10-Q (1), PRE 14A (1), PREM14A (1), PRER14A (1), S-3/A (1)

  • Latest filingsAnnual report (10-K) Jun 28, 2022
    Quarterly report (10-Q) Feb 9, 2023
    Proxy statement (DEF 14A) Jul 27, 2022
    Latest 8-K (8-K) Jun 14, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73